// App-Quantinova.ai

: Statin use and outcomes of patients (pts) with metastatic castration resistant prostate cancer (mCRPC) being treated with abiraterone (Abi).

Researchers

Presenter

  • Jacob A Gordon

Principal Investigators

  • Bernhard J. Eigl

  • Jennifer A. Locke

  • Gregory Russell Pond

  • Cyrus Chehroudi

  • Daniel Khalaf

  • Kim N. Chi

  • Michael E. Cox

Medical Centers

  • Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada

  • British Columbia Cancer Agency, Vancouver, BC, Canada

  • The University of British Columbia, Vancouver, BC, Canada

  • McMaster University, Hamilton, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • CB-7598

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved